XM does not provide services to residents of the United States of America.
S
S

Stryker

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

Stryker Files For Offering Of € Denominated Notes, Size Not Disclosed - Filing

BRIEF-Stryker Files For Offering Of € Denominated Notes, Size Not Disclosed - Filing Sept 4 (Reuters) - Stryker Corp SYK.N : STRYKER FILES FOR OFFERING OF € DENOMINATED NOTES, SIZE NOT DISCLOSED - FILING Source text for Eikon: [ID:n0001193125-24-212577] Further company coverage: SYK.N
S

U.S. STOCKS NetEase, Wolfspeed, B. Riley

BUZZ-U.S. STOCKS ON THE MOVE-NetEase, Wolfspeed, B. Riley Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell in volatile trading on Thursday, as rising Treasury yields pressured stocks ahead of Federal Reserve Chair Jerome Powell's speech at Jackson Hole that could offer clues on the possibility of a rate cut next month.
A
B
N
S
U
U
U
E
S
A

U.S. STOCKS Evogene, Stryker, Opera

BUZZ-U.S. STOCKS ON THE MOVE-Evogene, Stryker, Opera Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell in volatile trading on Thursday, as rising Treasury yields pressured stocks ahead of Federal Reserve Chair Jerome Powell's speech at Jackson Hole that could offer clues on the possibility of a rate cut next month.
A
B
B
I
N
U
U
U
E
S
A

Stryker rises on deal to acquire Vertos Medical

BUZZ-Stryker rises on deal to acquire Vertos Medical ** Shares of medical device maker Stryker SYK.N rise 1.1% to $348.86 ** Co says it would acquire privately held Vertos Medical to expand its minimally invasive pain management portfolio ** Deal gives SYK access to Vertos' minimally invasive treatment for chronic lower back pain caused by lumbar s
S

Stryker to acquire Vertos Medical

BRIEF-Stryker to acquire Vertos Medical Aug 22 (Reuters) - Stryker Corp SYK.N : STRYKER ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE VERTOS MEDICAL, INC., EXPANDING INTERVENTIONAL PAIN MANAGEMENT SOLUTIONS STRYKER: CO & VERTOS MEDICAL WILL CONTINUE TO OPERATE AS SEPARATE ENTITIES & PROCEED WITH BUSINESS AS USUAL UNTIL DEAL CLOSES Source text for Eikon
S

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.